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For decades it has been known that rats used in research can 
develop antibodies to a Cardiovirus that is antigenically similar to 
Theiler murine encephalomyelitis virus (TMEV) of mice.4,6,10,12,13,20 
Recent reports on the prevalence of antibodies in rats to this 
Cardiovirus vary from approximately 0.6% of sera tested from 
research rats in North America10 to 54.4% in a survey of 18 Brazil-
ian research facilities.3,6,20 Multiple designations have been used 
to identify the Cardiovirus that infects rats, including Theiler-like 
virus of rats,13 Theiler murine encephalomyelitis virus (TMEV),20 
rat enterovirus,1 rat encephalomyelitis virus,7 rat cardiovirus,15 
and recently rat theilovirus.2 We have elected to refer to the virus 
as rat theilovirus (RTV), consistent with 1 of the cited references,2 
to indicate the relation of the rat virus to TMEV of mice and to 
identify it as a rat-specific agent.
The first report of natural infection of rats with a Cardiovirus 
was in 1964 with the discovery of MHG virus.12 The finding re-
sulted from an isolated observation in which a few rats in a large 
research colony displayed clinical signs indicative of central ner-
vous system deficits, including incoordination, torticollis, circling, 
and tremors. The MHG virus recovered from infected rats was an-
tigenically crossreactive with TMEV strain GDVII and had physi-
cal properties consistent with viruses in the Picornaviridae family. 
The virus was propagated in cell culture, and neurologic disease 
was reproduced when virus was inoculated into suckling mice 
and suckling rats.12 Subsequent serologic studies using crossneu-
tralization, complement fixation, and hemagglutination inhibition 
assays further substantiated the antigenic relatedness between 
MHG virus and multiple strains of TMEV.4,11 In addition, sera 
from ‘normal’ rats contained antibodies to the newly identified 
Theiler-like virus of rats, suggesting widespread infection of the 
virus in research rat colonies.12 More recently in Japan, a Theiler-
like virus was isolated after intracranial inoculation of newborn 
Wistar rats with intestinal homogenates from TMEV GDVII-se-
ropositive rats.13 Inoculated rats did not develop clinical signs 
of infection, but virus was cultivated in BHK21 cells from brain 
homogenates of the 10-d-old Wistar rats inoculated intracrani-
ally. Physiochemical properties of the virus, designated NSG910, 
were consistent with those of the Cardiovirus genus. Sequence 
analysis also showed that NSG910 was a Cardiovirus in the family 
Picornaviridae that was related to, but distinct from MHG virus, 
and strains of TMEV. This report served to further document the 
existence of a unique Cardiovirus of rats closely related to, but 
distinct from, TMEV strains.13 In a recent report from Brazil, neo-
natal mice and rats inoculated with intestinal homogenates from 
rats with antibodies to TMEV strain GDVII developed neurologic 
signs of flaccid hindlimb paralysis and tremors. In addition, brain 
homogenates from the affected animals were positive by RT-PCR 
for cardioviral RNA.20
Picornavirus virions are approximately 30 nm in diameter, non-
enveloped, with icosahedral symmetry and a single-stranded, 
positive-sense RNA genome.19 Encephalomyocarditis virus and 
Theilovirus are 2 species of Cardiovirus in the Picornaviridae fam-
ily. Encephalomyocarditis virus species includes mengovirus, Maus 
Elberfeld virus, and Columbia SK virus.7 Strains of Theilovirus 
species include TMEV, Vilyuisk virus, and RTV.13,18,22 Most often 
studied are the TMEV strains, which are classified according to 
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maintained in DMEM supplemented with 10% FBS and 10 μg/
ml ciprofloxacin were used to cultivate virus. Culture plates (di-
ameter, 6 cm) were seeded with 1 × 106 cells, inoculated with virus 
when the cells reached 60% to 70% confluency, and incubated at 
33 °C for 1 h. Inocula were removed and agarose overlay media 
was added to plates, which were incubated at 33 °C until plaques 
were visible after 48 to 72 h of incubation. Single plaques were 
isolated and used to generate stocks of virus that were tittered 
according to standard methods.
RTV1 was propagated by using plaque-purified virus to in-
oculate BHK21 cells (at approximately 80% confluency) in 75-cm2 
tissue culture flasks (Corning, Lowell, MA) at a multiplicity of in-
fection of 0.1. Cultures were incubated at 33 °C and 5% CO2 for 1 
h then the inoculum was replaced with fresh growth medium for 
additional incubation. When cytopathic effect was greater than or 
equal to 90%, 3 freeze–thaw cycles were performed on cells and 
supernatant combined, the cellular material was pelleted at 3000 
× g for 15 min at 4 °C, and the virus-containing supernatant was 
harvested and stored at –80 °C until used for animal inoculations 
or until further concentrated and purified.
Electron microscopy. RTV1 was concentrated and purified by 
polyethylene glycol and salt precipitation followed by cesium 
chloride gradient ultracentrifugation as previously described.5 To 
determine the ultrastructure of the virus, viral preparations were 
pelleted by centrifugation at 41,000 rpm for 1 h at 4 °C in a SW41-
Ti rotor (Beckman Coulter, Fullerton, CA). Chilled 1% ammonium 
acetate was used to resuspend the virus overnight at 4 °C. A 7-µl 
sample was placed on a 300-mesh carbon-coated copper grid and 
allowed to settle for 5 min. Excess solution was wicked off, and a 
drop of 1.3% phosphotungstic acid (pH 7.0) was added and the 
virus particles stained for approximately 10 min. The grids were 
evaluated at 80 kV in a transmission electron microscope (1200EX, 
JEOL, Tokyo, Japan).
Sequencing. The genomic sequence of the RTV1 isolate was 
obtained by using RT-PCR and nucleotide sequencing. RNA was 
extracted from the supernatant of BHK21 cell cultures infected 
with plaque-purified RTV1 using a QIAmp Viral RNA Mini kit 
(Qiagen, Valencia, CA) according to the manufacturer’s protocol. 
Twelve oligonucleotide primer pairs were designed by using Dis-
cover Studio Gene software package (Accelrys, San Diego, CA) 
and the nucleotide sequence of NSG190 (GenBank accession no. 
AB090161) as a reference to generate overlapping amplicons that 
were 600 to 800 bp in length (Table 1). Primer pairs spanned from 
nucleotide position 112 to 7929 of the 8021-nucleotide genome of 
NSG910. RT-PCR was performed on extracted RNA with primer 
pairs at concentrations of 0.6 µM each by using a 1-step RT-PCR 
kit with Q Solution (Qiagen) according to the manufacturer’s pro-
tocol. Thermocycler parameters consisted of an initial reverse 
transcription step of 50 °C for 30 min followed by 1 cycle at 95° for 
15 min to activate the DNA polymerase and 40 cycles consisting 
of denaturation at 94 °C for 1 min, annealing at 49 °C for 1 min, 
and extension at 72 °C for 2 min with a final extension at 72 °C 
for 10 min. Amplified products were separated on agarose gels 
containing ethidium bromide and purified with Montage PCR 
Centrifugal Filter Devices (Millipore, Bedford, MA) or Zymogen 
gel DNA Recovery Kit (Zymo Research, Orange, CA). Sequence 
information for the termini of the viral genomic RNA were ob-
tained through rapid amplification of cDNA ends (RACE) by us-
ing 5′ and 3′ RACE Systems kit (Invitrogen, Carlsbad, CA) and 
associated gene specific primers according to the manufacturer’s 
their neurovirulence after intracerebral inoculation. Included are 
the highly neurovirulent GD VII and FA strains23 and the less 
virulent, more persistent DA, BeAn 8386, WW, and TO (Theiler 
original) strains.9,17,22 Studies have shown that the virus repli-
cates in the alimentary tract and is shed in the feces of infected 
mice.15,19 Mice rarely show clinical disease when infected under 
natural conditions; however, neurologic manifestations have been 
reported.21,24
Sentinel animals typically are used to survey rodent colonies 
for the presence or absence of infectious agents. Outbred stocks 
are frequently used as sentinels because of their vigor, relatively 
low cost, and ability to mount a robust humoral immune response 
to infectious agents.8,14 Sprague–Dawley (SD) and CD rats are 2 
stocks that are commonly used as sentinels for rat colonies. The 
origins of the SD rat (Rattus norvegicus) date back to the 1920s as a 
result of mating Wistar stock with a hybrid rat stock of unknown 
origin. In the 1950s, an SD breeding stock was cesarean derived 
in an effort to improve microbiologic status. This nucleus of ce-
sarean-derived rats formed the foundation of the CD rat stock.25 
Because SD and CD rat stocks have a common ancestry, they fre-
quently are considered to be interchangeable for the purpose of 
sentinel animals.
In the studies reported here, we isolated and propagated a 
novel strain of Theilovirus, referred to as RTV1, from the feces of 
infected SD rats. The entire genome of RTV1 was sequenced and 
compared with those of isolates of TMEV and NSG910, the only 
other isolate of RTV to be sequenced in its entirety. In addition, we 
evaluated the susceptibility of SD and CD outbred rats to RTV1 
after oral inoculation with the virus.
Materials and Methods
Viral isolation. Neonatal SD rats (Harlan Sprague Dawley, 
Indianapolis, IN) were exposed biweekly to approximately 240 
ml dirty bedding from a single cage of rats that had antibodies 
that reacted with TMEV strain GDVII and parvoviral antigens 
and were fecal positive for rat parvovirus and rat minute virus 
by PCR. Fecal pellets (30 cm3) from 3-wk-old SD rat pups were 
homogenized manually in Tris–EDTA buffer (50 mM Tris, 1 mM 
EDTA, pH 8.7; Sigma–Aldrich, St Louis, MO) at a total volume of 
80 ml. Aliquots of the fecal homogenate were sonicated (Model 
100, Fisher Scientific, Pittsburgh, PA) on ice at the maximum set-
ting for 6 cycles (30 s on, 30 s off) followed by centrifugation at 
10,000 × g for 10 min at 4 °C. The resultant supernatant was sub-
jected to precipitation and concentration by addition of 1 M NaCl 
and 8% (w/v) polyethylene glycol 8000 (Fischer Scientific, Fair 
Lawn, NJ). After overnight incubation, the precipitated material 
was pelleted by centrifugation at 10,000 × g for 15 min at 4 °C, 
resuspended in 4 ml PBS, passed sequentially through 0.45- and 
0.22-μm filters, and frozen at –20 °C. Thawed fecal filtrates (250 
μl) were placed on monolayers of BHK21 cells (70% confluent; 
CCL10, American Type Culture Collection, Manassas, VA) for 1 
h at 37 °C, after which the inocula were poured off, cells were 
washed in PBS, and maintained in DMEM (SH30243.02, HyClone, 
Logan, UT) supplemented with 10% FBS (S11150, Atlanta Biologi-
cals, Atlanta, GA) and 10 μg/ml ciprofloxacin in an atmosphere 
of 5% CO2 and 37 °C. Cultures were split 1:20 when cells reached 
confluency, and cultures were monitored for cytopathic effect by 
using an inverted microscope.
Plaque purification and propagation. RTV1 was plaque purified 
as previously described5 with a few modifications. BHK21 cells 
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Qiagen) and a robotic workstation (BioRobot M48 Workstation, 
Qiagen) according to the manufacturer’s protocols. Briefly, 1 fe-
cal pellet or approximately 20 mg of mesenteric lymph node was 
placed in a sterile 2-ml tube with a 5 mm steel ball and 400 μl 
buffer RLT added (Qiagen). All mixtures were disrupted and ho-
mogenized in a tissue lyser (Qiagen). Fecal samples were agitated 
at 30 Hz for 10 s and tissue samples at 20 Hz for 2 min. Lysates 
from feces were centrifuged for 10 min at 3000 × g and those from 
and lymph node were spun for 10 min at 13,000 × g; RNA was 
extracted from the resulting supernatants.
Two oligonucleotide primers (212f, 5′ ATT TTC CGG CCC AGG 
CTA AGA G 3′; 392r, 5′ CTT AGA TCT CCA ACC ACG TCG C 3′) 
were designed to conserved sequences in the 5′ untranslated re-
gion of TMEV strains (GenBank accession nos. X56019, M20301, 
M20562, and U33045) and RTV-NSG910 (AB090161) by using the 
Prime program (GCG Wisconsin package, Genetics Computer 
Group, Madison, WI). Primer specificity was verified by using the 
Basic Local Alignment Search Tool (BLAST, National Center for 
Biotechnology Information, Bethesda, MD). RTV1 RT-PCR was 
performed by using a 1-step RT-PCR kit with Q Solution (Qiagen) 
according to the manufacturer’s directions (see Sequencing) and 
by using primers 212f and 392r and an annealing temperature 
of 63 °C. RT-PCR products were subjected to electrophoresis in 
agarose gels containing ethidium bromide and were visualized 
under UV light. Positive RT-PCR reactions produced a 185-nucle-
otide product. All samples were tested in duplicate.
Multiplex fluorescent immunoassay. TMEV strain GDVII viral 
particles were purified by cesium chloride gradient centrifugation 
and covalently coupled to carboxylated polystyrene microspheres 
(Luminex, Austin, TX) at a concentration of 2 µg protein per 106 
microspheres and then stored at 4 °C until use. TMEV strain GD-
VII mouse antigen is cross-reactive with and routinely used by the 
Research Animal Diagnostic Laboratory for detection of antiRTV 
antibodies. A LiquiChip workstation (Qiagen) was used to process 
the rat serum samples for detection of the anti-RTV antibodies 
per manufacturers’ protocol. Baseline values were set according 
to that used by the Research Animal Diagnostic Laboratory at 
the University of Missouri. The following serologic parameters 
were used to delineate antiRTV antibody status: sera with values 
greater than 250 in multiplexed fluorescent immunoassays were 
classified as positive for antiRTV antibodies; sera with values of 
protocol (Table 2). Sequencing of purified products was done in 
forward and reverse directions for the 12 internal primer sets and 
in duplicate for the termini by the University of Missouri DNA 
Core Facility (Columbia, MO). Sequence data were assembled by 
using Sequencher Software (Gene Codes, Ann Arbor, MI). Dis-
crepancies in base identification were resolved through manual 
editing by using associated chromatograms. Sequence homolo-
gies were evaluated by using ClustalW alignment and phyloge-
netic analysis with the Discover Studio Gene software package 
(Accelrys, San Diego, CA).
Rats and sample collection. Four-week-old male CD rats were 
acquired from Charles River Laboratories (Charlotte, NC) and 
4-wk-old male SD rats were acquired from Harlan Sprague Daw-
ley (Indianapolis, IN). Rats were documented to be free of en-
doparasites, ectoparasites, Mycoplasma pulmonis, Helicobacter spp., 
known enteric and respiratory bacterial pathogens, antibodies to 
RTV, Sendai virus, pneumonia virus of mice, rat corona viruses, 
reovirus, rat parvoviruses, lymphocytic choriomeningitis virus, 
Hantaan virus, mouse adenovirus, Encephalitozoon cuniculi, and 
Clostridium piliforme. The animal care and procedures were ap-
proved and in accordance with the University of Missouri’s Ani-
mal Care and Use Committee. Rats were monitored daily, and 
neither analgesics nor supportive care was needed throughout 
the course of the study.
Rats were separated into a control group (n = 6) and an experi-
mental group (n = 10) for each rat stock. All rats were pair-housed 
for the entire study. Oral gavage with a 20-gauge ball-point needle 
was used to administer inoculum in all experiments. Experimen-
tal rats each were inoculated with 2.5 × 106 PFU of RTV1. Con-
trol groups were inoculated with uninfected BHK21 cell lysates, 
processed in the same manner as infected BHK21 cell cultures. 
Prior to inoculation on day 0 and on days 14, 28, and 56 there-
after, blood was collected from the lateral saphenous veins and 
feces were collected directly from the rats. Serum was separated 
and stored at –20 °C until antibody evaluation, and fecal samples 
were stored at –80 °C until processed for RT-PCR evaluation. Rats 
were euthanized by an inhaled overdose of carbon dioxide 56 
d after inoculation. Terminal blood samples were obtained by 
cardiocentesis.
RT-PCR. RNA was extracted from fecal and tissue samples by 
using magnetic beads (MagAttract RNA tissue Mini M48 kit, 
Table 1. Primer pairs used for sequencing the RTV1 genome
Primer sequence (5′ to 3′)
Amplicon size (bp) Location (nt)Sense Antisense
CGTCCTCCCTATTCCAACTAC GGGCTTGAGAAAGACCATTC 781 112–892
TGTAGCGACCTCACAGTAG GGTCAAGAAGTAAAGGAGCC 765 733–1497
GGAACATACTTGGTAATGCTGC TACTGGAGGGGCGTAAGAAC 760 1438–2197
TGGATGGTTTACCCACACC GCTAGTGTAACTAGTCTGGCG 789 2049–2837
AACAGGCAATGCAGGCAAC ACTGTTGGATGTGGCACTG 692 2725–3416
TGCTTTCTTGCTTTTCTCACC TTCAAACCCATAGTCATGTAGC 796 3341–4136
AACCATGCCCCCTTTTCCAC TTTGAACCACGACATGAGCC 753 3990-4742
TCCTCCAACCTCTCCTCTTC CGAACGTAATCCGCCTATC 746 4607–5352
TTTTGCCCAACATGGCTC AGCTACACAGACTTCATAGTCC 785 5215–5999
CGCAAAAAGAGGCGCTAAG GGCAGGAAAATTTCATGGGC 789 5891–6679
ATTACACAGGAACTTGTGGAAG CAGTGGAATGTGAGGCATC 793 6531–7323
CGCTTTCAGACAAACCCTG CTGGAACAACTACTCCAATCC 754 7176–7929
nt, nucleotides
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DA. Consistent with NSG190 and other Picornaviridae, RTV1 
contains a single, large 6924-nucleotide open reading frame 
from positions 1050 to 7973, which codes for the viral polypro-
tein. In addition, a 5′ untranslated region was present, as was 
a 3′ untranslated region that terminated with a polyA tail. In-
terestingly, the RTV1 genome was 73 nucleotides greater than 
that reported for NSG910, with 71 of these nucleotides being 
present in a single stretch at the 5′ untranslated region of the 
genome. Sequence alignments of the first 125 nucleotides of the 
5′ untranslated region of RTV with those of the TMEV strains 
GDVII, BeAn, DA (NC001366, M16020, and M20301) and the 
first 54 nucleotides of NSG910 (AB090161) are presented in 
Figure 2. The 71 terminal 5′ nucleotides of RTV1 share 69% 
to 71% sequence identity with the 3 TMEV strains, indicating 
that, although not reported for NSG910, homologous regions 
to these additional 5′ bases of RTV are present in other closely 
related Picornaviridae. Similar to other strains in the Theilovirus 
species, a poly C tract was not present in the 5′ terminus.17
RTV1 RT-PCR sensitivity. Sensitivity of the RT-PCR assay was 
evaluated by using RNA extracted from cesium-chloride–purified 
cell culture preparations of RTV1. RNA concentration was de-
termined by spectrophotometry. Log-fold serial dilutions, from 
100 pg to 100 ag RTV1 RNA, were used to evaluate the detection 
limits of the RTV RT-PCR. RT-PCR products were detected at 1 fg 
RTV1 RNA (data not shown). Based on an approximate molecular 
weight of 4.55 ag per virion (calculated based on a single-stranded 
RTV genome size of 8094 and an average molecular mass of 339 
Da/nucleotide) and the assumption that samples were pure, this 
primer set detected as few as 220 viral particles per amplification 
reaction.
Susceptibility of SD and CD rats to RTV. To evaluate the sus-
ceptibility of 2 outbred stocks of rats to RTV1, groups of 4-wk-
old male SD and CD rats were inoculated by oral gavage with 
BHK21 cell lysates containing 2.5 × 106 PFU of RTV1 (n = 10 rats 
per stock) or uninfected BHK21 cell lysates (n = 6 rats per stock). 
The feces of rats were monitored for viral shedding by a RTV RT-
125 to 250 were classified as intermediate and potentially con-
taining antiRTV antibodies; and sera with values of less than 125 
were classified as negative. Sera in the intermediate range were 
further tested by the Research Animal Diagnostic Laboratory at 
the University of Missouri by an indirect fluorescent antibody as-
say that used GDVII as an antigen and were classified as positive 
or negative based on this assay.
Histologic preparations. Histologic sections were prepared from 
brain, duodenum, jejunum, ileum, cecum, kidney, liver, spleen, 
and lung samples collected at termination of the study. Tissues 
from all experimental and control rats were fixed in 10% neu-
tral buffered formalin for 24 h, trimmed, embedded in paraffin, 
cut into 5-µm sections, and stained with hematoxylin and eosin. 
Stained sections were surveyed microscopically for lesions consis-
tent with pathologic processes.
Statistical analysis. Seroconversion and fecal shedding data for 
experimentally inoculated rat stocks were compared by using the 
Fisher Exact test (SigmaStat 3.5, Systat Software, San Jose, CA). A 
P value of less than 0.05 was considered significant.
Results
Isolation and ultrastructure of RTV1. RTV1 was isolated from 
the feces of 3-wk-old SD rats that had been exposed since birth 
to dirty bedding from rats with serum antibodies against TMEV 
antigens. BHK21 cells inoculated with filtered fecal preparations 
from these rats displayed 100% cytopathic effect (rounding and 
detachment of cells) 24 h after the third and fourth passages. 
RTV1 was plaque purified and cultivated in subconfluent mono-
layers of BHK21 cells. Inoculating BHK21 cells with plaque-pu-
rified RTV1 at a multiplicity of infection of 0.1 and incubating 
cultures in an atmosphere of 5% CO2 at 33 °C produced visible 
cytopathic effect of cultured cells starting at 24 h postinoculation, 
with 90% to 100% cytopathic effect reached by 48 h postinocula-
tion. These cell culture conditions produced RTV1 viral titers of 
2.5 × 106 PFU/ml.
Cesium chloride ultracentrifuged preparations of RTV1 were 
negatively stained and subjected to transmission electron micros-
copy. RTV1 viral particles were approximately 30 nm in diameter 
with icosahedral symmetry (Figure 1), consistent with morphol-
ogy previously reported for picornaviruses.19
Analysis of RTV1 genome. The full-length nucleotide se-
quence of RTV1 was obtained by aligning overlapping RT-PCR 
fragments that spanned the RTV genome and 5′ and 3′ RACE 
products of the viral termini. Overlapping RT-PCR products 
were sequenced in forward and reverse directions, and RACE 
products were sequenced in duplicate. The complete RTV1 ge-
nome (GenBank accession no. EU542581) contained 8094 nucle-
otides, which had approximately 95% nucleotide identity with 
NSG910 and 73% identity with TMEV strains GD7, BeAn, and 
Table 2. Primers used for sequencing of the 3′ and 5′ genomic termini
RACE protocol Primer Primer sequence (5′ to 3′)
3′ RACE GSP1 TTGGTTAAAGAAAGATTGGCCC
5′ RACE GSP1 GCTGCATCCACGTTTTTCG
GSP2 AGGGGCAGCACATACCCTTTTC
GSP3 AACCCTGTCATATTCCAAGTGG
GSP, gene-specific primer
Figure 1. Transmission electron micrograph of negatively stained RTV1 
particles cultivated in BHK21 cells and purified by cesium chloride gra-
dient centrifugation. Viral particles are approximately 30 nm in diam-
eter with icosahedral symmetry. Bar, 50 nm.
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maintains an approximate 70% sequence identity with the ho-
mologous fragment of strains of TMEV, further documenting the 
relationship of RTV1 to TMEV.
The SD and CD rat stocks are 2 of the most commonly used 
groups of outbred rats in research and are often viewed as bio-
logically comparable with one another. The relationship between 
SD and CD rats stems from the derivation of the CD stock from 
the original SD stock in the 1950s. Both the SD and CD rats are 
used for research applications that range from nutrition to aging 
studies. However, differences between the 2 stocks in lifespan 
and morbidity have been documented.16 In our study, we found 
differences between SD and CD rats in susceptibility to RTV1 
PCR assay and serum samples were monitored for antibodies to 
RTV by using a TMEV antigen-based multiplexed fluorescent im-
munoassay (Figures 3 and 4). In SD rats at 14 d postinoculation, 
100% of rats were shedding RTV1 in the feces, and 70% of the 
rats were positive for RTV serum antibodies. RTV fecal shedding 
steadily declined to 30% at the last time point evaluated (day 56 
postinoculation), at which time 90% of inoculated SD rats were 
seropositive for RTV. In contrast, RTV was detected in the feces of 
only 40% of the inoculated CD rats at 14 d postinoculation (Figure 
3) and not at any other time point. Moreover, serum antibodies 
to RTV in inoculated CD rats were not detected until 56 d pos-
tinoculation and then in only 20% of rats (Figure 4). Statistically 
significant (P < 0.05) differences in RTV fecal shedding between 
inoculated SD and CD rats were detected on postinoculation days 
14 and 28, and although the difference on postinoculation day 
56 was not statistically significant, a trend in viral shedding was 
evident. Statistically significant (P < 0.05) differences in serocon-
version to RTV between inoculated SD and CD rats were detected 
at all postinoculation time points. All sham-inoculated rats tested 
negative for RTV by fecal RT-PCR testing and serologic analysis 
throughout the study.
At the end of the study (56 d postinoculation), the mesenteric 
lymph nodes from rats were evaluated for RTV by RT-PCR, and 
the brain, duodenum, jejunum, ileum, cecum, kidney, liver, spleen 
and lung were evaluated for histopathologic lesions. The mesen-
teric lymph nodes from all experimental and control SD and CD rats 
tested negative for RTV, and no lesions attributable to RTV infection 
were noted in any of the organs examined. In addition, no clinical 
signs of disease occurred in any of the rats inoculated with RTV.
Discussion
Previous studies involving rat theilovirus strains MHG and 
NGS910 revealed that rats infected with these viruses developed 
antibodies that crossreact with antigens prepared from TMEV 
isolates that infect mice.4,13 These findings, in conjunction with 
sequence data from the NGS910 isolate, validated the existence 
of a distinct rat Cardiovirus that is related to, but different from 
mouse TMEV isolates. A paucity of information exists regarding 
RTV, yet according to serologic data, it is among the most preva-
lent viral pathogens infecting rats used in biomedical research.6,10 
In the current study, a novel isolate of RTV was cultured directly 
from the feces of rats and sequenced in its entirety. The genome 
size of RTV1 is comparable to those reported for TMEV isolates 
but is larger than that reported for NSG910, the only other RTV 
isolate to be sequenced. The RTV1 genome contains an additional 
71-nucleotide fragment in the noncoding region at the 5′ end of 
the genome that is absent from NSG910. As such, this fragment 
Figure 2. Alignment of the first 125 nucleotides of the 5′ untranslated 
regions of TMEV strains GDVII, BeAn (8386), and DA and RTV strains 
NSG910 and RTV1. Dashes indicate gaps in sequence.
Figure 3. Percentages of SD and CD rats shedding RTV1 in the feces after 
oral inoculation with RTV1 (experimental groups) or uninfected BHK21 
cell lysates (control groups). The presence of RTV1 in feces was detected 
by an RTV RT-PCR assay. SD experimental rats, n = 10; CD experimental 
rats, n = 10; SD control rats, n = 6; and CD control rats, n = 6.
Figure 4. Percentages of SD and CD rats developing antibodies to RTV1 
after oral inoculation with RTV1 (experimental groups) or uninfected 
BHK21 cell lysates (control groups). Serologic responses were detected 
by multiplexed fluorescent immunoassays using TMEV strain GDVII 
virus as antigen. SD experimental rats, n = 10; CD experimental rats, n = 
10; SD control rats, n = 6; and CD control rats, n = 6.
Susceptibility of SD and CD rats to RTV
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infection, as evidenced by differences in RTV1 fecal shedding and 
the development of antibodies to RTV1 after oral inoculation with 
the virus. At 14 d postinoculation, all inoculated SD rats shed 
RTV1 in their feces. In addition, the percentage of SD rats shed-
ding virus steadily declined over time until the end of the study 
(day 56 postinoculation), when 30% of the SD rats remained posi-
tive for virus in the feces. In contrast, RTV1 was detected in the 
feces of inoculated CD rats only at 14 d postinoculation, at which 
point only 40% of inoculated rats shed virus in the feces. Similar-
ly, SD rats developed antibodies to RTV1 more quickly than did 
CD rats: 70% of inoculated SD rats were seropositive at 14 d pos-
tinoculation. In contrast, the first seropositive CD rats were not 
detected until day 56 postinoculation, at which point only 20% of 
CD rats were seropositive compared with 90% of the inoculated 
SD rats. The reason for this difference is unknown but is likely 
due to genetic differences that exist between these 2 rat stocks. 
Because of the greater susceptibility of SD rats compared with 
CD rats to oral infection with RTV, the SD rat likely would be the 
better choice of stock for sentinel detection of RTV infections in 
research rat colonies. In circumstances that require use of CD rats 
as sentinels, a longer postexposure period should be used and a 
larger number of rats should be tested to allow serologic detection 
of RTV. Our data suggest the potential value of assessing possible 
differential susceptibilities to RTV infection in additional stocks 
and strains of rats.
Two of the CD rats and 1 of the SD rats orally inoculated with 
RTV shed virus at only 1 time point examined (postinoculation 
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the end of the study (postinoculation day 56). However, each of 
these rats was pair-housed with a rat that shed virus and serocon-
verted. Perhaps the virus present in the feces of the rats that failed 
to mount a humoral response to the virus was due to coprophagy 
of feces from infected cagemates but the virus did not cause ac-
tive infections in these rats. Alternatively, these rats may have 
been actively infected but failed to develop a detectable humoral 
immune response by the last time point examined. The serologic 
values from multiplexed fluorescent immunoassays for these 3 
experimental rats were similar to the values obtained from the 
sham-inoculated control rats (data not shown).
In rare circumstances, overt disease has occurred in murine 
hosts infected with Theilovirus spp.12,21,24 We did not observe any 
clinical or histologic signs of disease in any of the rats inoculated 
with RTV1. However, our study does not preclude the possibil-
ity of RTV1 causing disease in other rat strains or of additional 
virulent strains of RTV. Regardless, like numerous other murine 
pathogens, RTV may confound, alter, or invalidate research find-
ings even in the absence of overt disease. Investigation into the 
existence of additional strains of RTV and the potential effects of 
RTV in infected rats warrant further study.
In conclusion, we present the entire genomic sequence of a 
novel isolate of RTV (RTV1). The genome size is larger than the 
NSG910 isolate and comparable in size to genomes reported for 
strains of TMEV. In addition, we found a distinct differential sus-
ceptibility to infection between SD and CD rats experimentally 
inoculated with RTV1. SD rats exhibited prolonged fecal shed-
ding compared with that of CD rats, and a greater number of SD 
rats shed virus in the feces and developed antibodies to RTV than 
did CD rats over the 8 wk study. These data suggest that SD rats 
may be more effective than CD rats for use as sentinels to detect 
this pathogen in rat colonies.
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